Image: VCMP staff receive the award from Vaccine Research Center leaders during the retreat. From left: John Mascola (VRC), Barney Graham (VRC), Frank Arnold (VRC), Richard Koup (VRC), Barbara Brooks (VCMP), Scott Emerick (VCMP), Matt Westerman (VCMP), Adriel Ramkissoon (VCMP), Christopher Case (VCMP), and Judy Stein (VRC).

FREDERICK, Md. -- It has been used in clinical studies on four continents and has been tested in thousands of volunteers. It was produced at the Frederick National Laboratory for Cancer Research over a five-year span to meet increasing clinical demand, and it may play an ongoing role in the future of HIV research. 

Three-dimensional model of Simian Immunodeficiency Virus (SIV). National Cancer Institute image. Image by Sriram Subramaniam and Donald Bliss.

FREDERICK, Md. -- A new study led by investigators from the Frederick National Laboratory for Cancer Research in collaboration with colleagues from the Oregon Health and Science University (OHSU) utilizing a nonhuman primate model infected with Simian Immunodeficiency Virus (SIV) could have significant implications for future research into the prevention and potential cure of Human Immunodeficiency Virus (HIV).